RT Journal Article
SR Electronic
T1 Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005584
DO 10.1136/jitc-2022-005584
VO 11
IS 6
A1 Coveler, Andrew L
A1 Smith, David C
A1 Phillips, Tycel
A1 Curti, Brendan D
A1 Goel, Sanjay
A1 Mehta, Amitkumar N
A1 Kuzel, Timothy M
A1 Markovic, Svetomir N
A1 Rixe, Olivier
A1 Bajor, David L
A1 Gajewski, Thomas F
A1 Gutierrez, Martin
A1 Lee, Hun Ju
A1 Gopal, Ajay K
A1 Caimi, Paolo
A1 Heath, Elisabeth I
A1 Thompson, John A
A1 Ansari, Sahar
A1 Jacquemont, Celine
A1 Topletz-Erickson, Ariel
A1 Zhou, Peigen
A1 Schmitt, Michael W
A1 Grilley-Olson, Juneko E
YR 2023
UL http://jitc.bmj.com/content/11/6/e005584.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.